Skip to main content

Find Clinical Trials

Home
Conditions
Mycosis Fungoides

Clinical trial condition

Mycosis Fungoides

Explore clinical trials studying Mycosis Fungoides. Study availability and eligibility vary by location and protocol.

308 public trials 29 recruiting studies

Refine in advanced search Browse all conditions

Mycosis Fungoides trial results

Completed

Forodesine in the Treatment of Cutaneous T-Cell Lymphoma

NCT00501735

Conditions: Cutaneous T-cell Lymphoma (CTCL),, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: University of Alabama at Birmingham, Comprehensive Cancer Ctr Birmingham, Alabama, United States

Stanford University Medical Center Stanford, California, United States

Yale Cancer Center New Haven, Connecticut, United States

Moffitt Cancer Center Tampa, Florida, United States

View all 41 locations

View Trial Details

Completed

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

NCT00006379

Conditions: Amyloidosis, Anemia, Anemia, Refractory, +100 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

NCT00003887

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +123 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Quality of Life in Younger Leukemia and Lymphoma Survivors

NCT00956475

Conditions: Anxiety Disorder, Anxiety Disorders, Blast Crisis, +87 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

NCT00004075

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

NCT00089037

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +70 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer

NCT00806767

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France

View Trial Details

Completed

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

NCT00661999

Conditions: Amyloidosis, Anemia, Blood Protein Disorders, +72 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma

NCT00470405

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment

NCT00646139

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +53 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details